Wednesday, July 18, 2018
MZ Digital Marketing Agency
from Reuters: Health News https://ift.tt/2NlIyDg
Wednesday, July 18, 2018
Wednesday, July 18, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
(Reuters Health) - The 46 medicines given approval through 2017 as part of the U.S. Food and Drug Administration's Breakthrough Therapy program have often been sent to patients without a large double-blind study, direct measurement of benefit, or comparison with a placebo or existing treatment, according to a new analysis by researchers at Yale University and the Yale School of Medicine.
from Reuters: Health News https://ift.tt/2NlIyDg
from Reuters: Health News https://ift.tt/2NlIyDg
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment